Citigroup Inc Repligen Corp Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Repligen Corp stock. As of the latest transaction made, Citigroup Inc holds 93,398 shares of RGEN stock, worth $13.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

93,398

Previous 92,344 1.14%

Holding current value

$13.5 Million

Previous $11.6 Million 19.41%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$119.79 - $167.35 $126,258 - $176,386	1,054 Added 1.14%	93,398 $13.9 Million
Q2 2024 Aug 12, 2024	BUY	$120.0 - $182.95 $7.42 Million - $11.3 Million	61,805 Added 202.38%	92,344 $11.6 Million
Q1 2024 May 10, 2024	SELL	$170.78 - $208.42 $1.65 Million - $2.01 Million	-9,653 Reduced 24.02%	30,539 $5.62 Million
Q4 2023 Feb 09, 2024	BUY	$114.17 - $185.35 $443,778 - $720,455	3,887 Added 10.71%	40,192 $7.23 Million
Q3 2023 Nov 09, 2023	SELL	$138.78 - $176.51 $1.29 Million - $1.64 Million	-9,281 Reduced 20.36%	36,305 $5.77 Million
Q2 2023 Aug 10, 2023	BUY	$138.42 - $180.31 $356,431 - $464,298	2,575 Added 5.99%	45,586 $6.45 Million
Q1 2023 May 11, 2023	BUY	$154.26 - $198.1 $162,127 - $208,203	1,051 Added 2.5%	43,011 $7.24 Million
Q4 2022 Feb 09, 2023	SELL	$162.42 - $220.56 $489,209 - $664,326	-3,012 Reduced 6.7%	41,960 $7.1 Million
Q3 2022 Nov 10, 2022	BUY	$160.42 - $256.21 $2.56 Million - $4.09 Million	15,966 Added 55.04%	44,972 $8.42 Million
Q2 2022 Aug 10, 2022	SELL	$140.68 - $188.02 $902,321 - $1.21 Million	-6,414 Reduced 18.11%	29,006 $4.71 Million
Q1 2022 May 12, 2022	BUY	$161.19 - $257.96 $3.53 Million - $5.64 Million	21,880 Added 161.6%	35,420 $6.66 Million
Q4 2021 Feb 10, 2022	SELL	$247.59 - $304.47 $489,237 - $601,632	-1,976 Reduced 12.74%	13,540 $3.59 Million
Q3 2021 Nov 10, 2021	BUY	$194.77 - $324.21 $3.02 Million - $5.03 Million	15,516 New	15,516 $4.48 Million

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account